John A. Thompson
- Oncology top 0.1%
- Immunology top 0.5%
- Molecular Biology top 2%
- Epidemiology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Michael B. AtkinsCharles M. BalchDouglas S. ReintgenKelly M. McMastersJohn M. KirkwoodJohn F. ThompsonDaniel G. CoitJeffrey E. Gershenwald
- Topics
- Cancer Immunotherapy and Biomarkers (39 papers)CAR-T cell therapy research (27 papers)Immunotherapy and Immune Responses (16 papers)
- Cited by
- OncologyImmunologyDermatology
- Partner nations
- United StatesAustraliaSouth Africa
In The Last Decade
John A. Thompson
110 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 9.2k
- Immunology 4.3k
- Molecular Biology 3.4k
- Epidemiology 1.7k
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by John A. Thompson
This map shows the geographic impact of John A. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Thompson more than expected).
Fields of papers citing papers by John A. Thompson
This network shows the impact of papers produced by John A. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Thompson. The network helps show where John A. Thompson may publish in the future.
Co-authorship network of co-authors of John A. Thompson
This figure shows the co-authorship network connecting the top 25 collaborators of John A. Thompson. A scholar is included among the top collaborators of John A. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Thompson. John A. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 37 | |
| 4 | 6 | |
| 5 | 30 | |
| 6 | Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillancebreakdown → | 1544 |
| 7 | 48 | |
| 8 | 69 | |
| 9 | 46 | |
| 10 | 84 | |
| 11 | 6 | |
| 12 | 24 | |
| 13 | 93 | |
| 14 | 108 | |
| 15 | 83 | |
| 16 | 18 | |
| 17 | 19 | |
| 18 | Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. | 53 |
| 19 | 144 | |
| 20 | 4 |
About John A. Thompson
John A. Thompson is a scholar working on Oncology, Immunology and Hematology, having authored 111 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (39 papers), CAR-T cell therapy research (27 papers) and Immunotherapy and Immune Responses (16 papers). The work is most often cited by research in Oncology (9.2k citations), Immunology (4.3k citations) and Dermatology (808 citations). John A. Thompson has collaborated with scholars based in United States, Australia and South Africa. Frequent co-authors include Michael B. Atkins, Charles M. Balch, Douglas S. Reintgen, Kelly M. McMasters, John M. Kirkwood, John F. Thompson, Daniel G. Coit, Jeffrey E. Gershenwald, Shailender Bhatia and Merrick I. Ross. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.